Severe nephrotoxicity: a probable complication of cis-dichlorodiammineplatinum (II) and cephalothin-gentamicin therapy
- PMID: 7199128
- DOI: 10.1159/000225600
Severe nephrotoxicity: a probable complication of cis-dichlorodiammineplatinum (II) and cephalothin-gentamicin therapy
Abstract
A 53-year-old patient with metastatic testicular choriocarcinoma died of renal failure after treatment with cis-platinum and antibiotics. Serum creatinine was first noted to be elevated on day 8 of cis-dichlorodiammineplatinum (DDP) therapy. However, a sharp rise in its level occurred soon after the start of antibiotic therapy with cephalothin, gentamicin and carbenicillin. Renal failure was progressive in nature and persisted until death occurred on day 24 of therapy and after 8 days of antibiotic treatment. The most likely explanation for the progressive worsening of renal function in this patient was renal injury incurred by DDP and antibiotics. The combination of cephalothin-gentamicin should be discouraged in the treatment of patients receiving platinum.
Similar articles
-
Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.Cancer Treat Rep. 1978 May;62(5):693-8. Cancer Treat Rep. 1978. PMID: 657154
-
Acute renal failure associated with combined gentamicin and cephalothin therapy.Br Med J. 1973 May 19;2(5863):396-7. doi: 10.1136/bmj.2.5863.396. Br Med J. 1973. PMID: 4703097 Free PMC article.
-
Nephrotoxicity of combined cephalothin-gentamicin regimen.Arch Intern Med. 1975 Jun;135(6):850-2. Arch Intern Med. 1975. PMID: 1130930
-
Notes on some recent antibiotic literature. II. The new antibiotics.Eye Ear Nose Throat Mon. 1971 Dec;50(12):492-6. Eye Ear Nose Throat Mon. 1971. PMID: 4941105 Review. No abstract available.
-
Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis.Am J Clin Oncol. 2016 Oct;39(5):497-506. doi: 10.1097/COC.0000000000000081. Am J Clin Oncol. 2016. PMID: 24824144 Review.
Cited by
-
Comparative adverse effect profiles of platinum drugs.Drug Saf. 1995 Oct;13(4):228-44. doi: 10.2165/00002018-199513040-00003. Drug Saf. 1995. PMID: 8573296 Review.
-
Cisplatin: a review of clinical applications and renal toxicity.Pharm Weekbl Sci. 1985 Dec 13;7(6):237-44. doi: 10.1007/BF01959196. Pharm Weekbl Sci. 1985. PMID: 3909096 Review.
-
Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.Cancer Chemother Pharmacol. 1994;34(1):14-22. doi: 10.1007/BF00686106. Cancer Chemother Pharmacol. 1994. PMID: 8174197
-
Ototoxicity of cisplatinum in children and adolescents.Br J Cancer. 1990 Jun;61(6):927-31. doi: 10.1038/bjc.1990.208. Br J Cancer. 1990. PMID: 2372498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources